GLOFITAMAB vs GLUCARPIDASE: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
GLOFITAMAB vs GLUCARPIDASE: Safety Overview
| Metric | GLOFITAMAB | GLUCARPIDASE |
|---|---|---|
| Total FAERS Reports | 1,116 | 275 |
| Deaths Reported | 315 | 41 |
| Death Rate | 28.2% | 14.9% |
| Hospitalizations | 492 | 52 |
| Average Patient Age | 62.5 yrs | 44.3 yrs |
| % Female Patients | 53.2% | 36.4% |
| Manufacturer | Genentech, Inc. | BTG International Inc. |
| Route | INTRAVENOUS | INTRAVENOUS |
| Marketing Status | N/A | Prescription |